Cerity Partners
SCMP

Cerity Partners’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Cerity Partners’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,336
Closed -$293K – 604
2017
Q4 		$293K Buy
16,336
+85
+0.5% +$1.05K 0.02% 454
2017
Q3 		$192K Buy
16,251
+6,835
+73% +$76.7K 0.01% 547
2017
Q2 		$1.31M Buy
+9,416
New +$96K 0.11% 150

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Cerity Partners's SCMP Position: Q1 2018 in Review

Cerity Partners sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 16,336 shares — an estimated $293K sold.

Cerity Partners first reported a position in SCMP in Q2 2017 and held it in 3 quarters. The position peaked at $1.31M in Q2 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Cerity Partners reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Cerity Partners sold 16,336 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $293K.
  • Cerity Partners first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2017 and held it in 3 quarters.
  • Cerity Partners's Sucampo Pharmaceuticals, Inc. position peaked at $1.31M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Cerity Partners's 13F filing for Q1 2018, filed 15 May 2018.